Sign In
Buy AXNX
$70.98
+0 (+0%)
At Close: Feb 13, 2025
Axonics Provides Update on Inter Partes Review Proceedings
04:54pm, Thursday, 21'st Mar 2024
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two
Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System
09:56am, Friday, 15'th Mar 2024
Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
06:00am, Thursday, 14'th Mar 2024
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunct
Axonics Responds to ITC Action by Medtronic
04:01pm, Thursday, 29'th Feb 2024
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received notice that Medtronic has filed a complaint with the U.S. International Trade Commission (ITC), along
Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates
06:41pm, Wednesday, 28'th Feb 2024
Axonics Modulation Technologies (AXNX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.01 per share a year
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Axonics, Inc
4 Stocks Backed by High Efficiency to Enrich Your Portfolio
09:05am, Wednesday, 31'st Jan 2024
Invest in companies like Axonics (AXNX), Enerpac Tool Group (EPAC), Cardinal Health (CAH) and Acuity Brands (AYI) due to higher efficiency levels.
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
06:30am, Wednesday, 31'st Jan 2024
MARLBOROUGH, Mass. , Jan. 31, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a reporte
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Axonics, Inc
Why Axonics Stock Soared Today
07:38pm, Monday, 08'th Jan 2024
Axonics has agreed to be acquired by Boston Scientific for $71 per share in cash. Assuming the deal receives the approval of shareholders and regulators, it should close in the first half of 2024.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
04:55pm, Monday, 08'th Jan 2024
NEW YORK , Jan. 8, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Axonics, Inc. (NASDAQ: AXNX) and its board of directors concerning the proposed acquisit
Why Is Axonics (AXNX) Stock Up 20% Today?
11:28am, Monday, 08'th Jan 2024
Axonics (NASDAQ: AXNX ) stock is rising higher on Monday following news that Boston Scientific (NYSE: BSX ) is acquiring the company for $3.7 billion. That has Boston Scientific agreeing to purchase A
Axonix Stock Hits 52-Week High on Buyout Buzz
11:13am, Monday, 08'th Jan 2024
The shares of Axonix Inc (NASDAQ:AXNX) are soaring today, after news that Boston Scientific (BSX) is acquiring the medical equipment name for approximately $3.7 billion, or $71 per share.
MILWAUKEE , Jan. 8, 2024 /PRNewswire/ -- Ademi LLP is investigating Axonics (Nasdaq: AXNX) for possible breaches of fiduciary duty and other violations of law in its transaction with Boston Scientifi
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
08:20am, Monday, 08'th Jan 2024
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Axonics, Inc. (NASDAQ: AXNX) to Boston Scientific Corporation for $71.00 in cash per shar
